Genetic screening, lipid profile testing, and IMT measurements were performed on聽a聽series of 33 severe FH patients (19 homozygous) on LDL apheresis treatments (LDL聽447 卤 151 mg/dL, age range 6-60 years). Data were then compared with literature IMT-LDL data for normal subjects, mild FH patients, and severe FH patients (18, 41, and 6 studies, respectively).
Age-adjusted IMT was linearly related to LDL levels over a wide range of values (<500聽mg/dL), except for the severe FH no-apheresis cohort. Alternatively, our severe FH population (mostly on apheresis) did follow the mild FH/control age-adjusted IMT-LDL relation.
In severe FH, measuring LDL levels is more predictive of increased IMT than genetic screening.